Literature DB >> 18691543

Beyond genetics: surprising determinants of cell fate in antitumor drugs.

Andrew J Holland1, Don W Cleveland.   

Abstract

In this issue of Cancer Cell, Gascoigne and Taylor (2008) report their findings of following 10,000 single cells incubated with three classes of antimitotic drugs, including paclitaxel (taxol). This extensive analysis reveals a previously unappreciated complexity in response to such drugs and demonstrates that it is more than genetics that determines cell life or death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691543      PMCID: PMC3132553          DOI: 10.1016/j.ccr.2008.07.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  10 in total

Review 1.  Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint.

Authors:  Conly L Rieder; Helder Maiato
Journal:  Dev Cell       Date:  2004-11       Impact factor: 12.270

Review 2.  Targeted anti-mitotic therapies: can we improve on tubulin agents?

Authors:  Jeffrey R Jackson; Denis R Patrick; Mohammed M Dar; Pearl S Huang
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

3.  Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.

Authors:  Karen E Gascoigne; Stephen S Taylor
Journal:  Cancer Cell       Date:  2008-07-24       Impact factor: 31.743

Review 4.  The origin of numerical chromosome abnormalities.

Authors:  P A Jacobs; T J Hassold
Journal:  Adv Genet       Date:  1995       Impact factor: 1.944

5.  Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint.

Authors:  Daniela A Brito; Conly L Rieder
Journal:  Curr Biol       Date:  2006-06-20       Impact factor: 10.834

6.  Aneuploidy acts both oncogenically and as a tumor suppressor.

Authors:  Beth A A Weaver; Alain D Silk; Cristina Montagna; Pascal Verdier-Pinard; Don W Cleveland
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

Review 7.  On the road to cancer: aneuploidy and the mitotic checkpoint.

Authors:  Geert J P L Kops; Beth A A Weaver; Don W Cleveland
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

8.  Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5.

Authors:  Jue Shi; James D Orth; Tim Mitchison
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 9.  The spindle-assembly checkpoint in space and time.

Authors:  Andrea Musacchio; Edward D Salmon
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04-11       Impact factor: 94.444

10.  Examining the link between chromosomal instability and aneuploidy in human cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  J Cell Biol       Date:  2008-02-18       Impact factor: 10.539

  10 in total
  4 in total

1.  Centriole duplication: A lesson in self-control.

Authors:  Andrew J Holland; Weijie Lan; Don W Cleveland
Journal:  Cell Cycle       Date:  2010-07-27       Impact factor: 4.534

2.  Caspase-3-mediated degradation of condensin Cap-H regulates mitotic cell death.

Authors:  S-K Lai; C-H Wong; Y-P Lee; H-Y Li
Journal:  Cell Death Differ       Date:  2010-12-10       Impact factor: 15.828

3.  A conserved G₁ regulatory circuit promotes asynchronous behavior of nuclei sharing a common cytoplasm.

Authors:  Dhanalakshmi R Nair; Cori A D'Ausilio; Patricia Occhipinti; Mark E Borsuk; Amy S Gladfelter
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

4.  Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer.

Authors:  Sadia Sarwar; Viacheslav M Morozov; Hamsa Purayil; Yehia Daaka; Alexander M Ishov
Journal:  Cell Death Dis       Date:  2022-10-13       Impact factor: 9.685

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.